Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Anti-clotting medications increase the risk of bleeding
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Therefore, we do not make separate payment for these packaged items or services
The dosage of BPC 157 and duration of treatment may vary depending on the specific condition and individual needs
Place of Service codes 19, 21, 22, 23, 24, 26, 51, 52, and 61 do not allow the physician to separately bill the injection administration code
US$ 20.53
US$ 23.70
US$ 28.24
US$ 20.30
